Comparing routine versus on-demand leg blood flow tube during heart support
Part of Heart & circulation clinical trials.
This trial compares two ways of managing blood flow to your leg when you have a heart support device placed in the groin. One way uses a small extra tube (catheter) to keep blood flowing to your leg, and the other only adds it if needed. It aims to reduce leg complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years of age or older.
- You must be in cardiogenic shock, meaning your heart isn't pumping enough blood for your body.
- Your heart support device must be placed through the main artery in your groin (femoral artery).
- You or your legal representative must be able to understand the risks and benefits and sign a consent form.
- You must not have immediate signs of a blocked leg artery (like severe pain, numbness, or a cold leg) after the device is placed.
- You must not have a bleeding disorder that would make the procedure too risky.
- You cannot be pregnant, planning to become pregnant, or breastfeeding.
- You must not have had certain prior leg surgeries or a leg amputation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a small mechanical pump inside the heart plus careful monitoring with a special catheter can help people in shock after a heart attack. It compares this approach to standard care, aiming to improve survival and recovery.
This trial studies whether an “early” or more “conservative” approach to improving blood flow to the leg can prevent limb damage during a type of heart-lung machine called peripheral VA-ECMO. It may help reduce the risk of poor leg blood flow (ischemia) in people with severe heart failure-related shock.
This trial tests a device that continuously measures pressure in an arm or leg to help detect compartment syndrome in people on a heart-lung machine (VA-ECMO). It may help clinicians act sooner if pressure becomes dangerous, potentially reducing complications.
This study tests a new way to restore blood flow to the leg in people who have wounds or dead tissue on their foot and have run out of other treatment options. It's for those who have already tried angioplasty twice without success or have severely hardened small arteries.
This study follows adults with very poor blood flow to the foot or leg (with wounds or severe pain) who are having a revascularization procedure to improve circulation. It may help doctors understand outcomes after treatment and improve care for people with critical limb ischemia.
This trial is testing a new way to check the quality of leg bypass surgery while you're still in the operating room, using a special device. It may help ensure the bypass is working well right away, which could reduce the risk of future problems.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.